Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Management of Infusion Reactions to Systemic Anticancer Therapy: ESMO Clinical Practice Guidelines

Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv100–iv118.
Authors: S. Roselló, I. Blasco, L. García Fabregat, A. Cervantes and K. Jordan

Most anticancer treatments carry a risk for infusion reactions which incidence may increase when different agents are administered concomitantly. Although infusion reactions can be allergic or non-immune-mediated, the clinical manifestations are the same and require prompt assessment and appropriate intervention. These new ESMO Clinical Practice Guidelines provide tools to evaluate the risk of infusion reactions, to recognise the early signs and symptoms and include recommendations on how to document and manage them.

Download the PDF from Annals of Oncology

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.